Cascadian Therapeutics, Inc. CASC
No live quote for CASC yet.
CASC revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2017 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2017 | 2017-12-31 | 0 | 0 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | 0 | Not meaningful |
| FY 2015 | 2015-12-31 | 0 | 0 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | 0 | Not meaningful |
| FY 2013 | 2013-12-31 | 0 | 0 | Not meaningful |
| FY 2012 | 2012-12-31 | 0 | -145,000 | -100.00% |
| FY 2011 | 2011-12-31 | 145,000 | 127,000 | 705.56% |
| FY 2010 | 2010-12-31 | 18,000 | -2,060,000 | -99.13% |
| FY 2009 | 2009-12-31 | 2,078,000 | -38,217,000 | -94.84% |
| FY 2008 | 2008-12-31 | 40,295,000 | 36,585,000 | 986.12% |
| FY 2007 | 2007-12-31 | 3,710,000 | -269,000 | -6.76% |
| FY 2006 | 2006-12-31 | 3,979,000 | 366,000 | 10.13% |
| FY 2005 | 2005-12-31 | 3,613,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:06.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.